Qingdao Haier Biomedical Co.,Ltd

¥33.38As of Sun 8 Nov 2026, 12:00 UTC
SSE:688139Healthcare
Country China
PE (Fwd) •••
TSR 7Y CAGR 2.46%
Div yield 0.99%
ROE 5.96%
Medical Devices
Beta (5Y) 0.55
PE TTM 38.36
TSR TTM (3.01%)
Mkt cap ¥10.41B
ROIC 7.24%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥39
16.21%
(68.22%)
Hold 12|12|3|8|11
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.44
0.47
0.51
0.51
5.97%
9.02%
14.62%
15.42%
Revenue¥M
812.0
822.7
840.7
836.3
5.99%
10.52%
11.67%
5.28%
Peers (US$1.560B)
Cap (US$)
PE
1.590B
18.21x
1.519B
40.59x
1.553B
—
Capital
TTM
5Y
10Y
Leveragex
1.052
0.296
0.246
EBIT/Intx
0.217
0.102
0.101
Own earn%
(17.62)
58.34
58.34
Sh yield%
34.25
45.31
45.77
Owners
Insiders/Inst%
7.80
39.62
Short interest%
5.37
SBC / revenue%
3.96
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
3–15
$1 testx
—
Incr. ROIC%
7